Seqens Seqens

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Find Radio Compass News for Lurasidone HCl

    Client Email Product

    Lurasidone HCl

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    PRICE INFORMATION

    INTERMEDIATES

    DOSSIERs // Finished Dosage Formulations

    DRUG PRODUCT COMPOSITION

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS

    ANALYTICAL SOLUTION(s)

    DIGITAL CONTENT

    PharmaCompass
    Product SearchProduct Search
    API SUPPLIERS
    API Suppliers

    API Suppliers

    61
    US DMFs Filed

    US DMFs Filed

    32
    CEP/COS Certifications

    CEP/COS Certifications

    0

    JDMFs Filed

    JDMFs Filed

    1
    Other Certificates

    Other Certificates

    13
    Other Suppliers

    Other Suppliers

    46
    API REF. PRICE (USD / KG)
    2,115

    API Market Place

    9
    INTERMEDIATES
    32
    DOSSIERS // FDF
    USA (Orange Book)

    USA (Orange Book)

    93
    Europe

    Europe

    13
    Canada

    Canada

    30
    Australia

    Australia

    16
    South Africa

    South Africa

    0

    Uploaded Dossiers

    Uploaded Dossiers

    13
    GLOBAL SALES (USD Million)

    U.S. Medicaid

    7,826.00

    Annual Reports

    0

    FDF Market Place

    1
    EXCIPIENTS
    67
    PATENTS & EXCLUSIVITIES

    USFDA Orange Book Patents

    85

    USFDA Exclusivities

    0

    DIGITAL CONTENT

    Blog #PharmaFlow

    2

    News

    47
    REF STANDARD

    EDQM

    0

    USP

    0

    JP

    0

    Other Listed Suppliers

    7
    SERVICES
    1
    left grey arrow
    right gray arrow
    • TABLET;ORAL - 120MG
    • TABLET;ORAL - 20MG
    • TABLET;ORAL - 40MG
    • TABLET;ORAL - 60MG
    • TABLET;ORAL - 80MG
    Full View ScreenFull Screen View
    Macleods' Generic Lurasidone Hydrochloride Receives Approval in the U.S.
    Macleods' Generic Lurasidone Hydrochloride Receives Approval in the U.S.

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212124

    FDA
    09 Jun 2023
    Share Share
    Aurobindo's Generic Lurasidone Hydrochloride Receives Approval in U.S.
    Aurobindo's Generic Lurasidone Hydrochloride Receives Approval in U.S.

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208045

    FDA
    10 Mar 2023
    Share Share
    Alkem's Generic Lurasidone Hydrochloride Receives Approval in the U.S.
    Alkem's Generic Lurasidone Hydrochloride Receives Approval in the U.S.

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212244

    FDA
    13 Dec 2022
    Share Share
    MSN's Generic Lurasidone HCL Receives Approval in the U.S.
    MSN's Generic Lurasidone HCL Receives Approval in the U.S.

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208037

    FDA
    09 Sep 2022
    Share Share
    Watson Labs Teva `s Generic Lurasidone Hydrochloride Receives Approval in US
    Watson Labs Teva `s Generic Lurasidone Hydrochloride Receives Approval in US

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208016

    FDA
    08 Feb 2021
    Share Share
    BeiGene, Sumitomo-Roivant, Roche-JHL and more
    BeiGene, Sumitomo-Roivant, Roche-JHL and more

    https://www.fiercepharma.com/pharma-asia/fiercepharmaasia-beigene-s-short-seller-attack-sumitomo-roivant-deal-roche-jhl

    Angus Liu FIERCE PHARMA
    13 Sep 2019
    Share Share
    Roivant lines up $3B upfront in Sumitomo Dainippon deal 
    Roivant lines up $3B upfront in Sumitomo Dainippon deal 

    https://www.fiercebiotech.com/biotech/roivant-lines-up-3b-upfront-sumitomo-dainippon-deal

    Nick Paul FIERCEBIOTECH
    06 Sep 2019
    Share Share
    Emcure Pharms Generic Lurasidone Hydrochloride Receives Approval in US
    Emcure Pharms Generic Lurasidone Hydrochloride Receives Approval in US

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208058

    FDA
    06 Sep 2019
    Share Share
    Teva Pharms USA Generic Lurasidone Hydrochloride Receives Approval in US
    Teva Pharms USA Generic Lurasidone Hydrochloride Receives Approval in US

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208060

    FDA
    20 May 2019
    Share Share
    Piramal Health Care's Lurasidone hydrochloride Receives Approval in US
    Piramal Health Care's Lurasidone hydrochloride Receives Approval in US

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212091

    FDA
    26 Mar 2019
    Share Share
    Sun Pharma Global's Generic Lurasidone Hydrochloride Receives Approval in US
    Sun Pharma Global's Generic Lurasidone Hydrochloride Receives Approval in US

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208066

    FDA
    07 Jan 2019
    Share Share
    Amneal Pharm's Generic Lurasidone Hydrochloride Receives Approval in US
    Amneal Pharm's Generic Lurasidone Hydrochloride Receives Approval in US

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208002

    FDA
    03 Jan 2019
    Share Share
    Invagen Pharm's Generic Lurasidone Hydrochloride Receives Approval in US
    Invagen Pharm's Generic Lurasidone Hydrochloride Receives Approval in US

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208002

    FDA
    03 Jan 2019
    Share Share
    Lupin's Generic Lurasidone Hydrochloride Receives Approval in US
    Lupin's Generic Lurasidone Hydrochloride Receives Approval in US

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208031

    FDA
    03 Jan 2019
    Share Share
    Accord Healthcare's Generic Lurasidone Hydrochloride Receives Approval in US
    Accord Healthcare's Generic Lurasidone Hydrochloride Receives Approval in US

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208049

    FDA
    03 Jan 2019
    Share Share
    Torrent Pharm's Generic Lurasidone Hydrochloride Receives Approval in US
    Torrent Pharm's Generic Lurasidone Hydrochloride Receives Approval in US

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208055

    FDA
    03 Jan 2019
    Share Share
    NeuroRx Receives FDA Breakthrough Therapy Designation for NRX-101
    NeuroRx Receives FDA Breakthrough Therapy Designation for NRX-101

    https://www.businesswire.com/news/home/20181113005407/en/NeuroRx-Receives-FDA-Breakthrough-Therapy-Designation-NRX-101/?feedref=JjAwJuNHiystnCoBq_hl-bQQCakZDujohEJegUyaJwquReQ0P23MrIoWkrUSV24ZevRMp3sIgu8q3wq1OF24lT93qbEzrwa15HGbLqMObxbNWfZlBntHS6jpH5ROLXsTFMkl05DM8ABqeyBleEmzJA==

    BUSINESSWIRE
    13 Nov 2018
    Share Share
    Latuda (lurasidone hydrochloride) : Sumitomo D. Pharma vs. Alkem Laboratories
    Latuda (lurasidone hydrochloride) : Sumitomo D. Pharma vs. Alkem Laboratories

    https://insight.rpxcorp.com/litigation_documents/13097249

    PATENT LITIGATION
    19 Oct 2018
    Share Share
    Latuda® (lurasidone HCl) : Sumitomo D. Pharma, Sunovion vs. Macleods Pharma
    Latuda® (lurasidone HCl) : Sumitomo D. Pharma, Sunovion vs. Macleods Pharma

    https://insight.rpxcorp.com/litigation_documents/13064957

    PATENT LITIGATION
    22 Sep 2018
    Share Share
    Latuda® (lurasidone HCl) : Sumitomo D. Pharma, Sunovion v. Macleods Pharma USA
    Latuda® (lurasidone HCl) : Sumitomo D. Pharma, Sunovion v. Macleods Pharma USA

    https://www.pharmacompass.com/pdf/news/Latuda-lurasidone-HCl-Sumitomo-D-Pharma-Sunovion-v-Macleods-Pharma-USA-1536920797.pdf

    PATENT LITIGATION
    13 Sep 2018
    Share Share
    Torrent Pharms' Generic Lurasidone Hydrochloride Receives Tentative Approval in US
    Torrent Pharms' Generic Lurasidone Hydrochloride Receives Tentative Approval in US

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208055

    FDA
    10 Sep 2018
    Share Share
    Latuda (lurasidone HCl) : Sumitomo, Sunovion Pharma v. Piramal Healthcare UK
    Latuda (lurasidone HCl) : Sumitomo, Sunovion Pharma v. Piramal Healthcare UK

    https://www.pharmacompass.com/pdf/news/Latuda-lurasidone-HCl-Sumitomo-Dainippon-Pharma-v-Piramal-Healthcare-UK-1536041780.pdf

    PATENT LITIGATION
    03 Sep 2018
    Share Share
    Latuda® (Lurasidone HCl) :Sumitomo Dainippon Pharma v. First Time US Generics
    Latuda® (Lurasidone HCl) :Sumitomo Dainippon Pharma v. First Time US Generics

    https://www.pharmacompass.com/pdf/news/latuda-lurasidone-hcl-sumitomo-dainippon-pharma-v-first-time-us-generics-1520833034.pdf

    PATENT LITIGATION
    08 Mar 2018
    Share Share
    Latuda® (Lurasidone HCl): Sumitomo Dainippon Pharma v. Accord Healthcare
    Latuda® (Lurasidone HCl): Sumitomo Dainippon Pharma v. Accord Healthcare

    https://www.pharmacompass.com/pdf/news/latuda-lurasidone-hcl-sumitomo-dainippon-pharma-v-accord-healthcare-1520833093.pdf

    PATENT LITIGATION
    08 Mar 2018
    Share Share
    Latuda® (Lurasidone HCl): Sumitomo Dainippon Pharma v. Invagen Pharmaceuticals
    Latuda® (Lurasidone HCl): Sumitomo Dainippon Pharma v. Invagen Pharmaceuticals

    https://www.pharmacompass.com/pdf/news/latuda-lurasidone-hcl-sumitomo-dainippon-pharma-v-invagen-pharmaceuticals-1520833252.pdf

    PATENT LITIGATION
    08 Mar 2018
    Share Share
    Latuda® (Lurasidone HCl) : Sumitomo Dainippon Pharma v. Par Pharmaceutical
    Latuda® (Lurasidone HCl) : Sumitomo Dainippon Pharma v. Par Pharmaceutical

    https://www.pharmacompass.com/pdf/news/latuda-lurasidone-hcl-sumitomo-dainippon-pharma-v-par-pharmaceutical-1520833507.pdf

    PATENT LITIGATION
    08 Mar 2018
    Share Share
    FDA Grants Sunovion’s Latuda Expanded Approval for Bipolar Depression
    FDA Grants Sunovion’s Latuda Expanded Approval for Bipolar Depression

    https://www.biospace.com/article/fda-grants-sunovion-s-latuda-expanded-approval-for-bipolar-depression-in-pediatric-patients/

    Alex Keown BIOSPACE
    06 Mar 2018
    Share Share
    Latuda® (Lurasidone Hcl): Sumitomo Dainippon Pharma v. Emcure Pharmaceuticals
    Latuda® (Lurasidone Hcl): Sumitomo Dainippon Pharma v. Emcure Pharmaceuticals

    https://www.pharmacompass.com/pdf/news/Latuda-Lurasidone-Hcl-Sumitomo-Dainippon-Pharma-v-Emcure-Pharmaceuticals-1520248132.pdf

    PATENT LITIGATION
    13 Feb 2018
    Share Share
    Pharma companies fall foul of ABPI’s Code of Practice
    Pharma companies fall foul of ABPI’s Code of Practice

    http://www.pharmatimes.com/news/pharma_companies_fall_foul_of_abpis_code_of_practice_1214319

    Selina McKee PHARMA TIMES
    14 Dec 2017
    Share Share
    Teva Pharms's Generic Lurasidone Hydrochloride Receives Tentative Approval In US
    Teva Pharms's Generic Lurasidone Hydrochloride Receives Tentative Approval In US

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208060

    FDA
    28 Jul 2017
    Share Share
    Sunovion’s Latuda® (lurasidone HCI) Receives Health Canada Approval
    Sunovion’s Latuda® (lurasidone HCI) Receives Health Canada Approval

    http://www.businesswire.com/news/home/20170721005471/en/Sunovion%E2%80%99s-Latuda%C2%AE-lurasidone-HCI-Receives-Health-Canada/?feedref=JjAwJuNHiystnCoBq_hl-WBlLQO14j4QZPTyX5CYOnwC4VjN53jumZRlnzhBoBxGrCOi9QzgjCezTS3Nw_X6kJUrpSBm-Hav1w-UkdSlG3ltkRSnqzf6ourQGu_UA28CzZCGORvG0LE20YOvo49uqw==

    BUSINESSWIRE
    24 Jul 2017
    Share Share
    Zydus Pharm’s Generic Lurasidone HCL Receives Tentative Approval In US
    Zydus Pharm’s Generic Lurasidone HCL Receives Tentative Approval In US

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208052

    FDA
    07 Jul 2017
    Share Share
    Par Pharm’s Generic Lurasidone Hcl Receives Tentative Approval In US
    Par Pharm’s Generic Lurasidone Hcl Receives Tentative Approval In US

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207948

    FDA
    19 May 2017
    Share Share
    Japanese Companies Make Cautious Return to Indian Pharma Market
    Japanese Companies Make Cautious Return to Indian Pharma Market

    http://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/japanese-companies-make-cautious-return-to-indian-pharma-market/articleshow/56320837.cms

    Divya Rajagopal ECONOMIC TIMES
    04 Jan 2017
    Share Share
    Watson's Generic Lurasidone Hydrochloride Receives Approval In US
    Watson's Generic Lurasidone Hydrochloride Receives Approval In US

    http://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208016

    FDA
    05 Dec 2016
    Share Share
    Invagen's Generic Lurasidone Hydrochloride Receives Tentative Approval In US
    Invagen's Generic Lurasidone Hydrochloride Receives Tentative Approval In US

    http://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208028

    FDA
    02 Dec 2016
    Share Share
    Aurobindo's Generic Lurasidone HCL Receives Tentative Approval In US
    Aurobindo's Generic Lurasidone HCL Receives Tentative Approval In US

    http://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208045

    FDA
    18 Nov 2016
    Share Share
    Aurobindo's Geneic Lurasidone HCL Receives Tentative Approval In US
    Aurobindo's Geneic Lurasidone HCL Receives Tentative Approval In US

    http://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208045

    FDA
    18 Nov 2016
    Share Share
    TV pharma ad spending, AbbVie's Humira and Pfizer's Lyrica continue to dominate
    TV pharma ad spending, AbbVie's Humira and Pfizer's Lyrica continue to dominate

    http://www.fiercepharma.com/marketing/october-tv-pharma-ad-spending-abbvie-humira-and-pfizer-lyrica-continue-to-dominate

    Beth Snyder Bulik FIERCE PHARMA
    07 Nov 2016
    Share Share
    Accord Healthcare's Generic Lurasidone Hcl Receives Tentative Approval In US
    Accord Healthcare's Generic Lurasidone Hcl Receives Tentative Approval In US

    https://www.pharmacompass.com/pdf/news/accord-healthcares-generic-lurasidone-hcl-receives-tentative-approval-in-us-1476531133.pdf

    FDA
    12 Oct 2016
    Share Share
    Pharma TV ad spending rises in April, led by big brand names
    Pharma TV ad spending rises in April, led by big brand names

    http://www.fiercepharma.com/marketing/pharma-tv-ad-spending-rises-april-led-by-big-brand-names-from-pfizer-abbvie-and-sunovion

    Beth Snyder Bulik FIERCE PHARMA
    04 May 2016
    Share Share
    Fake smiles star in Otsuka and Lundbeck's DTC push for Rexulti in depression
    Fake smiles star in Otsuka and Lundbeck's DTC push for Rexulti in depression

    http://www.fiercepharmamarketing.com/story/fake-smiles-star-otsuka-and-lundbecks-dtc-push-rexulti-depression/2016-03-09

    Beth Snyder Bulik FIERCE PHARMA MARKETING
    10 Mar 2016
    Share Share
    Sunovion announces positive results for antipsychotic drug
    Sunovion announces positive results for antipsychotic drug

    http://www.biospectrumasia.com/biospectrum/news/221329/sunovion-announces-positive-results-antipsychotic-drug

    Biospectrum Bureau BIOSPECTRUM ASIA
    21 May 2015
    Share Share
    Takeda, Orexigen end CV study for obesity drug Contrave
    Takeda, Orexigen end CV study for obesity drug Contrave

    http://www.fiercepharmaasia.com/story/takeda-orexigen-end-cv-study-obesity-drug-contrave/2015-05-12

    Ej Lane FIERCE PHARMA ASIA
    13 May 2015
    Share Share
    Sumitomo Dainippon, Takeda call it quits on Japan Latuda agreement
    Sumitomo Dainippon, Takeda call it quits on Japan Latuda agreement

    http://www.fiercepharmaasia.com/story/sumitomo-dainippon-takeda-call-it-quits-japan-latuda-agreement/2015-05-07

    Ej Lane FIERCE PHARMA ASIA
    07 May 2015
    Share Share
    Sumitomo Dainippon says Latuda for schizophrenia in Japan misses PhIII aims
    Sumitomo Dainippon says Latuda for schizophrenia in Japan misses PhIII aims

    http://www.fiercepharmaasia.com/story/sumitomo-dainippon-says-latuda-schizophrenia-japan-misses-phiii-aims/2015-04-27

    Ej Lane FIERCE PHARMA ASIA
    27 Apr 2015
    Share Share
    It's Like Viagra for Pharma Ads: Pfizer's $1.4 Billion Marketing Blitz
    It's Like Viagra for Pharma Ads: Pfizer's $1.4 Billion Marketing Blitz

    http://www.bloomberg.com/news/articles/2015-03-30/pain-and-erectile-dysfunction-make-pfizer-biggest-in-drug-ads

    Cynthia Koons BLOOMBERG BUSINESS
    30 Mar 2015
    Share Share
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    Metrochem Lurasidone HCl

    Access Virtual Booth

    Contact Supplier

    View Presentation

    veranova-m-2024-04-22

    Access Virtual Booth

    Contact Supplier

    View Presentation

    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search